Arcadia Biosciences
RKDA
17 hedge funds and large institutions have $484K invested in Arcadia Biosciences in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
524% more capital invested
Capital invested by funds: $77.4K → $484K (+$406K)
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
31% more funds holding
Funds holding: 13 → 17 (+4)
14.19% more ownership
Funds ownership: 2.85% → 17.03% (+14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$312K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$224K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$41.3K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$24.7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$148 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$24 |
RKDA Hedge Fund Activity: Q1 2026 in Review
17 of the 8,206 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q1 2026, worth a combined $484K — up 524% from $77.4K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new RKDA positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $312K. The largest seller was Osaic Holdings, exiting entirely with an estimated $148 sold.
- 17 institutional investors held Arcadia Biosciences (RKDA) as of Q1 2026, up from 13 in Q4 2025.
- Funds reported $484K of Arcadia Biosciences stock for Q1 2026, up 524% quarter-over-quarter.
- 7 funds opened new Arcadia Biosciences positions in Q1 2026 and 2 closed out, a net change of +5 holders.
- The largest Arcadia Biosciences buyer in Q1 2026 was Armistice Capital, an estimated $312K added.
- The largest Arcadia Biosciences seller in Q1 2026 was Osaic Holdings, an estimated $148 sold.
Based on aggregated 13F filings for Q1 2026.